Skip to main content
Log in

Effect of intravenous administration of paracetamol on morphine consumption in cancer pain control

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Objective

The present study aimed to examine the effectiveness of intravenous administration of paracetamol added to morphine in the control of cancer pain and its possible contribution as reduction of opioid consumption and opioid-related side effects.

Materials and methods

A total of 43 patients with chronic cancer pain without neuropathic origin aged between 18 and 76 years and receiving step 2 treatment according to the World Health Organization analgesic ladder were included. Patients were randomized to receive intravenous administration of saline (control) or 1 g of paracetamol on top of morphine. Visual analog scale (VAS), patient rating index (PRI), Eastern Cooperative Oncology Group (ECOG) status, patient satisfaction, and safety were evaluated.

Main results

Both treatments resulted in improved VAS and PRI scores compared to baseline. However, groups did not differ in terms of VAS and PRI scores, morphine consumption, side-effect frequencies, laboratory values, ECOG status, and patient satisfaction.

Conclusions

Although safe and there are signals for a true analgesic efficacy, our results failed to confirm any benefits of add-on treatment with intravenous administration of paracetamol. However, the study was underpowered, and future studies in this important area need to be wary of background noise and the risk of a type II error.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Axelsson B, Stellborn P, Ström G (2008) Analgesic effect of paracetamol on cancer related pain in concurrent strong opioid therapy. A prospective clinical study. Acta Oncol 47:891–895

    Article  CAS  PubMed  Google Scholar 

  2. Blayney MR, Ryan JD, Malins AF (2003) Propofol target-controlled infusions for sedation—a safe technique for the non-anaesthetist? Br Dent J 194:450–452

    Article  CAS  PubMed  Google Scholar 

  3. Botting R, Ayoub SS (2005) COX 3 and the mechanism of action of paracetamol/acetaminophen. Prostaglandins, Leukotrienes and Essential Fatty Acids 72:85–87

    Article  CAS  Google Scholar 

  4. Botting RM (2000) Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis 31(Suppl 5):S202–210

    Article  CAS  PubMed  Google Scholar 

  5. Brune K, Zeilhofer HU (2003) Antipyretic analgesics. In: Melzack R, Wall PD (eds) Handbook of pain management. Churchill Livingstone, Edinburg, pp 1139–1153

    Google Scholar 

  6. Cherny N (2003) The management of cancer pain. In: Melzack R, Wall PD (eds) Handbook of pain management. Churchill Livingstone, Edinburg, pp 641–666

    Chapter  Google Scholar 

  7. Delbos A, Boccard E (1995) The morphine sparing effect of propacetamol in orthopedic postoperative pain. J Pain Symptom Manage 10:279–286

    Article  CAS  PubMed  Google Scholar 

  8. Fitzgibbon DR, Chapman CR (2001) Cancer pain: assessment and diagnosis. In: Loeser JD (ed) Bonica's management of pain, IIIth edn. Lipponcott Williams & Wilkins, Philadelphia, pp 623–658

    Google Scholar 

  9. Graham GG, Scott KF, Day RO (2005) Tolerability of paracetamol. Drug Safety 28:227–240

    Article  CAS  PubMed  Google Scholar 

  10. Graham GG, Scott KF (2005) Mechanism of action of paracetamol. Am J Ther 12:46–55

    Article  PubMed  Google Scholar 

  11. Hardy J, Reymond E, Charles M (2005) Acetaminophen in cancer pain. J Clin Oncol 23:1586

    Article  PubMed  Google Scholar 

  12. Hernandez-Palazon J, Tortosa JA, Martinez-Lage JF, Perez-Flores D (2001) Intravenous administration of propacetamol reduces morphine consumption after spinal fusion surgery. Anesth Analg 92:1473–1476

    Article  CAS  PubMed  Google Scholar 

  13. New South Wales Therapeutic Advisory Group (2005) IV paracetamol-where does it sit in hospital practice? Current Opinion October 1-8.

  14. Peduto VA, Ballabio M, Stefanini S (1998) Efficacy of propacetamol in the treatment of postoperative pain. Morphine-sparing effect in orthopedic surgery. Italian Collaborative Group on Propacetamol. Acta Anaesthesiol Scand 42:293–298

    Article  CAS  PubMed  Google Scholar 

  15. Pelissier T, Allou A, Caussade F, Dubray C, Cloarec A, Lavarenne J, Eschalier A (1996) Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine-3 receptors: in vivo and in vitro evidence. J Pharmacol Exp Ther 278:8–14

    CAS  PubMed  Google Scholar 

  16. Pettersson PH, Jakobsson J, Öwall A (2005) Intravenous acetaminophen reduced the use of opioids compared with oral administration after coronary artery bypass grafting. J Cardiothorac Vasc Anesth 19:306–309

    Article  CAS  PubMed  Google Scholar 

  17. Prescott LF (2000) Therapeutic misadventure with paracetamol: fact or fiction. Am J Ther 7:99–114

    Article  CAS  PubMed  Google Scholar 

  18. Rodrigez MJ, Contreras D, Galvez R, Castro A, Camba MA, Busqueta C, Herrera J (2003) Double-blind evaluation of short-term analgesic efficacy of orally administered dexketoprofen trometamol and ketorolac in bone cancer pain. Pain 104:103–110

    Article  Google Scholar 

  19. Schug SA (2005) Clinical pharmacology of non-opioid and opioid analgesics. In: Justins DM (ed) PAIN 2005-An Updated Review. IASP Press, Seattle, pp 31–38

    Google Scholar 

  20. Sinatra RS, Jahr JS, Reynolds LW, Viscusi ER, Groudine SB, Payen-Champenois C (2005) Efficacy and safety of single and repeated administration of 1 gram intravenous acetaminophen injection (paracetamol) for pain management after major orthopedic surgery. Anesthesiology 102:822–831

    Article  CAS  PubMed  Google Scholar 

  21. Stockler M, Vardy J, Pillai A, Warr D (2004) Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: A randomized, double-blind, placebo-controlled cross-over trial. J Clin Oncol 22:3389–3394

    Article  CAS  PubMed  Google Scholar 

  22. World Health Organization (1998) Cancer pain relief and palliative care in children. WHO, Geneva

    Google Scholar 

  23. World Health Organization (1996) Cancer pain relief, with a guide to opioid availability, 2nd edn. World Health Organization, Geneva

    Google Scholar 

  24. Zernikow B, Smale H, Michel E, Hasan C, Jorch N, Andler C (2006) Paediatric cancer pain management using the WHO analgesic ladder—results of a prospective analysis from 2265 treatment days during a guality improvement study. Eur J Pain 10:587–595

    Article  PubMed  Google Scholar 

  25. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD et al (2005) Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113:9–19

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kader Keskinbora.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tasmacioglu, B., Aydinli, I., Keskinbora, K. et al. Effect of intravenous administration of paracetamol on morphine consumption in cancer pain control. Support Care Cancer 17, 1475–1481 (2009). https://doi.org/10.1007/s00520-009-0612-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-009-0612-8

Keywords

Navigation